St. James's Place plc
St. James's Place plc (STJPF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for St. James's Place plc (STJPF), covering cash flow, earnings, and balance sheets.
St. James's Place plc (STJPF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for St. James's Place plc STJPF financial performance.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $10.13B | $15.78B | $11.05B | $7.96B |
Cost of Revenue | $10.13B | $14.11B | $9.56B | $6.61B |
Gross Profit | $0.00 | $1.66B | $1.49B | $1.35B |
Gross Profit Ratio | $0.00 | $0.11 | $0.13 | $0.17 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $1.10B | $1.42B | $1.008B |
Operating Expenses | $0.00 | $1.10B | $1.38B | $970.30M |
Total Costs & Expenses | -$9.68B | $15.21B | -$10.93B | -$7.58B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $0.00 | $13.30M | $20.80M | $18.60M |
EBITDA | $472.10M | $580.60M | $21.00M | $387.10M |
EBITDA Ratio | $0.05 | $0.04 | $0.002 | $0.05 |
Operating Income | $452.60M | $567.30M | $23.10M | $374.20M |
Operating Income Ratio | $0.04 | $0.04 | $0.002 | $0.05 |
Other Income/Expenses (Net) | $19.50M | $9.70M | $31.50M | $10.80M |
Income Before Tax | $472.10M | $577.00M | $54.60M | $385.00M |
Income Before Tax Ratio | $0.05 | $0.04 | $0.005 | $0.05 |
Income Tax Expense | $238.80M | $411.90M | $226.20M | $223.30M |
Net Income | $233.30M | $165.10M | -$171.70M | $161.60M |
Net Income Ratio | $0.02 | $0.01 | -$0.02 | $0.02 |
EPS | $0.43 | $0.30 | -$0.31 | $0.30 |
Diluted EPS | $0.43 | $0.30 | -$0.31 | $0.29 |
Weighted Avg Shares Outstanding | $543.44M | $552.17M | $545.19M | $546.00M |
Weighted Avg Shares Outstanding (Diluted) | $546.27M | $552.90M | $545.19M | $548.10M |
The company's financials show resilient growth, with revenue advancing from $7.96B in Q2 2023 to $10.13B in Q4 2024. Gross profit remained healthy with margins at N/A in Q4 2024 compared to 17% in Q2 2023. Operating income hit $452.60M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $472.10M. Net income rose to $233.30M, while earnings per share reached $0.43. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan